Nexus Surgical & Medicare Limited has delivered impressive financial performance for the third quarter of FY26, with the Board of Directors approving unaudited results that showcase strong growth across revenue and profitability metrics. The company's results were approved during a board meeting held on February 14, 2026, at the company's registered office in Vasai, Maharashtra.

Quarterly Financial Performance

The company demonstrated exceptional quarterly performance with significant improvements in both revenue and profitability metrics compared to the previous year.

The company's sales revenue surged to ₹293.08 lakhs in Q3 FY26, nearly doubling from ₹148.39 lakhs in the corresponding quarter of the previous year. This remarkable 97.55% growth in sales was accompanied by strong operational efficiency, resulting in net profit growth of 49.76% to ₹17.01 lakhs.

Nine-Month Performance Analysis

For the nine-month period ended December 31, 2025, Nexus Surgical and Medicare Limited maintained its growth trajectory with consistent improvements across key financial parameters.

The nine-month results reflect sustained business momentum, with sales growing 37.34% to ₹582.19 lakhs and net profit increasing 21.29% to ₹49.62 lakhs compared to the same period in the previous year.

Operational Metrics and Expenses

The company's expense management showed mixed trends during the quarter. Total expenses for Q3 FY26 stood at ₹270.38 lakhs compared to ₹133.21 lakhs in Q3 FY25. Key expense components included:

• Purchase of stock-in-trade: ₹97.63 lakhs (Q3 FY26) vs ₹63.30 lakhs (Q3 FY25)
• Other expenses: ₹204.16 lakhs (Q3 FY26) vs ₹98.83 lakhs (Q3 FY25)
• Employee benefits expense: ₹0.62 lakhs (Q3 FY26) vs ₹4.87 lakhs (Q3 FY25)

The company benefited from a positive change in inventories of stock-in-trade worth ₹32.13 lakhs during Q3 FY26, compared to a negative change of ₹33.89 lakhs in the corresponding quarter last year.

Earnings Per Share and Capital Structure

Basic and diluted earnings per share for Q3 FY26 stood at ₹0.31, representing an improvement from ₹0.21 in Q3 FY25. For the nine-month period, earnings per share increased to ₹0.91 from ₹0.75 in the previous year. The company's paid-up equity share capital remained stable at ₹547.19 lakhs, consisting of equity shares of ₹10 each.

Corporate Governance and Compliance

The financial results were reviewed and recommended by the audit committee before board approval. The company's statutory auditors, Satya Prakash Natani & Co., conducted a limited review of the results. The company reported no shareholder or investor complaints during the quarter ended December 31, 2025, reflecting strong corporate governance practices.

Nexus Surgical & Medicare Limited has issued a clarification to BSE Limited regarding recent significant price movements in its securities, responding to a surveillance department inquiry dated January 2, 2026.

Company's Response to BSE Inquiry

The healthcare company addressed BSE's email reference No. L/SURV/ONL/PV/AJ/2025-2026/3264 through an official communication dated January 3, 2026. The response was signed by Managing Director Ram Swaroop Joshi (DIN: 07184085) and submitted to BSE's surveillance department at Phiroze Jeejeebhoy Towers, Mumbai.

Market-Driven Price Movement

Nexus Surgical and Medicare Limited attributed the significant price movement in its securities to market conditions, describing it as purely market-driven. The company emphasized that the volatility was not linked to any specific corporate developments or undisclosed information.

The management clarified that there is no undisclosed or price-sensitive information requiring disclosure to the exchange at this time. Additionally, the company confirmed no impending announcements or corporate actions that would necessitate immediate market notification.

Regulatory Compliance Assurance

The company reaffirmed its commitment to regulatory compliance under SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. Key compliance aspects highlighted include:

• Prompt information sharing with stock exchanges on operational matters
• Timely disclosure of events affecting company performance
• Continued adherence to material event reporting requirements
• Ongoing commitment to transparency in corporate communications

Nexus Surgical and Medicare Limited assured BSE that it will continue to promptly inform exchanges of all material events, information, and actions as required under the regulatory framework. The company's registered address is located at Gala No. 4, Building No. 1, Saarthak Square Industrial Park, Sativali, Vasai (East), Palghar.